TScan Therapeutics, Inc.
TCRX • NASDAQ
TScan Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gavin MacBeath, with a market cap of $60.3M.
Market Cap$60.3M
Employees154.0
CEOGavin MacBeath
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
TScan Therapeutics, Inc. FAQ
Common questions about TScan Therapeutics, Inc.
TScan Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $2.4M.
TScan Therapeutics, Inc. has approximately 154 employees.